Decision for pirfenidone and nintedanib: For patients with mild or moderate IPF based on pulmonary function tests who do not have underlying liver disease -Current data are insufficient to direct a firm choice between pirfenidone and nintedanib, -diarrhea and liver function test abnormalities with nintedanib versus nausea and rash with pirfenidone 2. Nintedanib & Pirfenidone […]